Cover
Vol. 8 No. 1 (2018)

Published: June 30, 2018

Pages: 55-63

Research Article

Effect of Ovarian Stimulation Protocol on Embryo Quality in IVF-ICSI

Abstract

Background:Defects in reproduction that may involve both the male & female partners result in the inability to procreate which is known as infertility. The use of assisted reproductive technologies (ART’s) has been increasing over the past three decades. Many efforts have been done to compensate for unsatisfac-tory results in in-vitro fertilization (IVF) procedures, so that patients undergo different ovarian stimulation protocols to control retrieval of multiple oocytes in a single cycle. Although ovarian stimulation has an important role in ART’s, it may also have detrimental effects on oocyte quality, embryo quality, and IVF outcomes. Objectives: To assess the effect of long agonist versus antagonist protocols on oocyte and embryo quality in IVF-Intracytoplasmic sperm injection (ICSI). Patients,Materials and Methods: This comparative study was done on the embryos of seventy one infertile fe-males who were undergoing Intracytoplasmic sperm injection (ICSI) treatment regardless to the presence or absence of previous trials. These patients were divided into two groups, 45 of them treated with agonist protocol and other 26 patients treated with antagonist protocol. First oocyte retrieved was used for further assessment. Of the 71 oocytes, there were eight immature oocytes (3 at germinal vesicle (GV) stage, 5 at metaphase I (MI) stage) and three abnormal oocytes, and these were excluded from the following ICSI treatment. Assessment and comparison of oocyte maturity, fertilization rate, cleavage rate and resulting embryo quality were done. Results:The results of the present study showed significant difference (p<0.05) in oocyte number and maturity but no significant (p>0.05) difference between the group treated with long agonist and those on antagonist protocol regarding fertilization rate, cleavage rate, and embryo quality. Conclusions:The type of protocol used in in-vitro fertilization has no detrimen-tal effect on oocyte or embryo quality.

References

  1. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R. The International Committee for Monitor- ing Assisted Reproductive Technology (ICMART) and the World Health Orga- nization (WHO) revised glossary on ART terminology. Hum Reprod. 2009; 24: 2683–2687.
  2. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Sys- tematic Analysis of 277 Health Surveys. PLoS Med. 2012; 9: 12.
  3. Bartoov B, Berkovitz A., Eltes F, Kogosovsky A, Yagoda A, Lederman H, Artzi S, Gross M, and Barak Y. Pregnan- cy rates are higher with intracytoplasmic morphologically selected sperm injection than with conventional intracytoplasmic injection Fertility and sterility, 2003; 80: 6. 1413-1419
  4. Parsanezhad M. E, Jahromi B. N, Re- zaee S , Kooshesh L, Alaee S. The Effect of Four Different Gonadotropin Protocols on Oocyte and Embryo Quality and Preg- nancy Outcomes in IVF/ICSI Cycles; A Randomized Controlled Trial. IJMS. 2017;42:1.
  5. Turhan N, Pekel A, Ayrim A, Kasap B, BAYRAK Ö. Effectiveness of HP-hMG versus r-FSH in patients under- going IVF/ ICSI cycles with moderate male-factor infertility. Turk J Med Sci. 2013; 43: 144-9.
  6. Mohamed MA, Sbracia M, Pac- chiartti A, Micara G, Linari A, Tranquil- li D, et al. Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study. Fertil Ster- il. 2006; 85: 1398-403.
  7. Khalaf M, ´ Mittre H, Levallet J, Ha- noux V, Denoual C, Herlicoviez M, Bon- namy P, Benhaim A. GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation path- way of aromatase expression in human granulosa cells. Reproductive BioMedi- cine Online. 2010; 21: 56– 65
  8. Albano, C., Felberbaum, R.E., Smitz, J. ‘Ovarian stimulation with HMG: results of a prospective random- ized phase III European study comparing the luteinizing hormonereleasing hor- mone (LHRH)-antagonist cetrorelix and the LHRHagonist buserelin. European Cetrorelix Study Group. Hum. Reprod. 2000; 15: 526–531.
  9. Prados F. J., Debrock S, Lemmen J. G.,and Agerholm I. The cleavage stage embryo. Human Reproduction, 2012; 27: S1. 150–171.
  10. Parsanezhad M. E, Jahromi B. N, Rezaee S , Kooshesh L, Alaee S. The Effect of Four Different Gonadotropin Protocols on Oocyte and Embryo Quali- ty and Pregnancy Outcomes in IVF/ICSI Cycles; A Randomized Controlled Trial. IJMS. 2017; 42: 1.
  11. Holte J, Berglund L, Milton K, Garello C, Gennarelli G, Revelli A, Ber- gh T. Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of em- bryos scored and transferred on day 2 af- ter oocyte retrieval. Hum Reprod. 2007; 22:548–557.
  12. Stensen MH, Tanbo T, Storeng R, Byholm T, Fedorcsak P. Routine morpho- logical scoring systems in assisted repro- duction treatment fail to reflect age-re- lated impairment of oocyte and embryo quality. Reprod Biomed Online. 2010; 21(1): 118-125.
  13. Macklon NS, Stouffer RL, Giu- dice LC & Fauser BC. The science be- hind 25 years of ovarian stimulation for in vitro fertilization. Endocrine Reviews. 2006; 27: 170–207
  14. Adamson GD, Abusief ME, Pa- lao L, Witmer J, Palao LM, Gvakharia M. Improved implantation rates of day 3 embryo transfers with the use of an au- tomated time-lapse-enabled test to aid in embryo selection. Fertil Steril. 2016; 105:369-375.
  15. Shrestha D , La X , Feng H. L. Com- parison of different stimulation protocols Iraqi Journal Of Embryos and Infertility Researches Vol.(8) Issue-1 (2018) used in in vitro fertilization: a review Ann Transl Med 2015;3(10):137
  16. Kim CH, You RM, Kang HJ, et al. GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI. Clin Exp Reprod Med. 2011; 38: 228- 33.
  17. Cheung L.P, Lam P.M, Lok I. H, Yu Chiu T.T, Yeung S.Y, Tjer C. C and Haines C.J. GnRH antagonist versus long GnRH agonist protocol in poor respond- ers undergoing IVF: a randomized con- trolled trial. Human Reproduction Vol. 2005; 20: 3. 616–621.
  18. Jaime M. K, James A. G, Akiva P. N, Meghan B. S, Alan S. B.Is bigger bet- ter: The association between follicle size and livebirth rate following IVF? Open Journal of Obstetrics and Gynaecology. 2012; 2: 361-366
  19. Kara K, Aydin T, Aran T, Turk- tekin N, Ozdemir B. Comparison of GnRH agonist and antagonist protocols in normoresponder patients who had IVF-ICSI. Archives of Gynecol Obstet. 2013; 288:1413–1416
  20. Beckers NGM, Macklon NS, Ei- jkemans MJC, Fauser BCJM. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovar- ian aging. Fertil Steril. 2002; 78: 291– 7.
  21. Kligman I, Rosenwaks Z. Dif- ferentiating clinical profiles: predicting good responders, poor responders, and hyperresponders. Fertil Steril 2001;76: 6. 1185–90.
  22. Loutradis D. , Drakakis P. & E. Vom- volaki & A. Antsaklis. Different ovarian stimulation protocols for women with diminished ovarian reserve. J Assist Re- prod Genet. 2007. 24: 597–611 Iraqi Journal Of Embryos and Infertility Researches Vol.(8) Issue-1 (2018)
  23. Nagy Z. P, Dozortsev D, M.D., Diamond M, Rienzi L, Ubaldi, F, Ab- delmassih R, and Greco E. Pronuclear morphology evaluation with subsequent evaluation of embryo morphology sig- nificantly increases implantation rates. Fertility and sterility; 2003. Vol. 80, No.1. 67-74.24. Valbuena D, Martin J, de Pablo JL, Remohi J, Pellicer A, Si- mon C.Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril. 2001; 76(5):962–968. 25. Halvaei I, Khalili M. A, Razi M. H, Agha-Rahimi A, and Nottola S. A. Impact of different embryo loading tech- niques on pregnancy rates in in vitro fer- tilization/embryo transfer cycles. J Hum Reprod Sci. 2013; 6(1): 65–69.